Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 8 de 8 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]
2.Tiene citas relacionadas
Correli CU, De Hert M. Antipsychotics for acute schizophrenia: making choices. Lancet 2013;382:919-20. [Ref.ID 96104]
3.Enlace a cita original
George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA. Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol 2013;69:1497-509. [Ref.ID 95885]
4. Cita con resumen
Kuehn BM. Off-label atypical antipsychotics. JAMA 2012;308:1198. [Ref.ID 93799]
5. Cita con resumen
Kuehn BM. Studies may not provide clear view of antipsychotics. JAMA 2012;307:1572. [Ref.ID 92761]
6. Cita con resumen
Anónimo. Quetiapine (Seroquel) and QT-interval prolongation. Med Lett Drugs Ther 2011;53:79-80. [Ref.ID 91713]
7. Cita con resumen
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]
8.
Caccia S. Biotransformation of post-clozapine antipychotics: pharmacological implications. Clin Pharmacokinet 2000;38:393-414. [Ref.ID 50704]
Seleccionar todas
 
 1 a 8 de 8